Alex Goldberg

Myriad Genetics Inc. (NASDAQ:MYGN) and Cognizant Technology Solutions Corporation (NASDAQ:CTSH) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/05/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Myriad Genetics Inc. (NASDAQ:MYGN) and Cognizant Technology Solutions Corporation (NASDAQ:CTSH).

Myriad Genetics Inc. (NASDAQ:MYGN) a molecular diagnostic company that focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States is currently up (+9.42%) on 3,039,495 shares traded after Myriad Genetics has been upgraded to Market Perform from Underperform at JMP Securities. Myriad Genetics Inc. (NASDAQ:MYGN) is currently up (+55.14%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Myriad Genetics Inc. (NASDAQ:MYGN)

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) a company that provides information technology, consulting, and business process outsourcing services worldwide is currently down (-6.17%) on 1,822,877 shares traded after Cognizant Reported Fourth Quarter and Full Year 2013 Results. Cognizant Technology Solutions Corporation (NASDAQ:CTSH) is currently down (-9.44%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Cognizant Technology Solutions Corporation (NASDAQ:CTSH)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com